ロード中...

Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors

Chronic myeloid leukemia (CML) has become a chronic disease, for which the chronic phase is manageable with tyrosine kinase inhibitor (TKI) therapy. Patients with optimal responses to TKIs have achieved long‐term survival, and treatment‐free remission (TFR) has since become an additional treatment g...

詳細記述

保存先:
書誌詳細
出版年:Am J Hematol
主要な著者: Cortes, Jorge, Rea, Delphine, Lipton, Jeffrey H.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Inc. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587857/
https://ncbi.nlm.nih.gov/pubmed/30394563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25342
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!